Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 1 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Excite Medical Of Tampa Bay LLC focuses on the Medical Devices & Mechanical Engineering technology area. The company currently has 3 pending office actions. These actions are distributed among 3 distinct examiners. Despite the involvement of multiple examiners, all 3 pending office actions are centralized within 1 distinct art unit. This indicates that while different individuals are reviewing the applications, they all belong to the same specialized technical group.
JANG, JAEICK is the busiest examiner for the portfolio, currently managing 1 busiest examiner pending action. With 3 pending office actions and 3 distinct examiners, the workload is evenly distributed. The concentration of all activity within 1 distinct art unit indicates that the company's medical device innovations fall under a very specific technical classification at the patent office. Practitioners should ensure consistency in their responses, as the 3 distinct examiners are likely in close proximity within the same art unit.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANG, JAEICK | 1 | 66.7% | +52.6% |
| ASHIMIU, MAUTIN ISAAC | 1 | 50.6% | +51.3% |
| BUGG, PAIGE KATHLEEN | 1 | 58.6% | +58.7% |
| LEDERER, SARAH B | 1 | 55.7% | +36.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18231608 | SPINAL DECOMPRESSION DEVICE WITH PNEUMATIC BODY HARNESS | ASHIMIU, MAUTIN ISAAC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18231669 | PROGRESSIVE SPINE UNLOCK | LEDERER, SARAH B | 24d overdue |
| 18231681 | SPINAL DECOMPRESSION CONTROLLER | BUGG, PAIGE KATHLEEN | 9d |
| 18747870 | Spinal Decompression Treatment Modulation System | JANG, JAEICK | — |
| 18231608 | SPINAL DECOMPRESSION DEVICE WITH PNEUMATIC BODY HARNESS | ASHIMIU, MAUTIN ISAAC | — |
| Art Unit | Apps |
|---|---|
| 3785 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18747870 | Spinal Decompression Treatment Modulation System | JANG, JAEICK | — | §102 | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18231608 | SPINAL DECOMPRESSION DEVICE WITH PNEUMATIC BODY HARNESS | ASHIMIU, MAUTIN ISAAC | 3785 | §102§103 | Final Rejection | — | Pending | Aug 08, 2023 |
| 18231681 | SPINAL DECOMPRESSION CONTROLLER | BUGG, PAIGE KATHLEEN | 3785 | §103DP | Final Rejection | 9d | Pending | Aug 08, 2023 |
| 18231669 | PROGRESSIVE SPINE UNLOCK | LEDERER, SARAH B | 3785 | §103 | Final Rejection | 24d overdue | Pending | Aug 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial